Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
prostate cancer
Devices
Olympus pushes deeper into oncology with $270M BioProtect deal
Olympus is moving deeper into prostate cancer care with the acquisition of BioProtect and its radiation-protection spacer technology.
Ayla Ellison
May 26, 2026 3:57pm
FDA flags concerns for AZ's camizestrant, Truqap ahead of adcomm
Apr 28, 2026 2:47pm
Oric chases Pfizer into phase 3 hailing prostate cancer edge
Apr 1, 2026 9:53am
FDA to end 9-month adcomm hiatus with review of AZ cancer drugs
Mar 6, 2026 11:16am
BioNTech’s B7-H3 ADC hits ph. 3 at half the size of Merck’s
Feb 27, 2026 10:31pm
Astellas says 'I do' to Vir's T-cell engager in $1.7B deal
Feb 23, 2026 5:00pm
